Results 31 to 40 of about 1,529,288 (217)
Aktualʹnì Pitannâ Farmacevtičnoï ì Medičnoï Nauki ta Praktiki, 2017 Creation of accessible domestic drug for the treatment and prevention of thrombotic venous damage, which would be able to adjust maximum range of disorders with minimal side effects, is actual direction of the pharmacology.
L. M. Maloshtan, A. S. Kalenichenko
doaj +1 more source
In vitro characterization of jellyfish venom fibrin(ogen)olytic enzymes from Nemopilema nomurai
Journal of Venomous Animals and Toxins including Tropical Diseases, 2017 Background Because jellyfish are capable of provoking envenomation in humans, they are considered hazardous organisms. Although the effects of their toxins are a matter of concern, information on the venom components, biological activity and pathological
Seong Kyeong Bae +8 more
doaj +1 more source
Heart India, 2020 Context: The main aim of the study is to find out efficacy, outcomes, and complications of thrombolytic therapy and surgery for obstructive prosthetic heart valve thrombosis (PHVT).
Zeeshan Mansuri +5 more
doaj +1 more source
Does thrombolytic therapy harm or help in ST elevation myocardial infarction (STEMI) caused by the spontaneous coronary dissection? [PDF]
Vojnosanitetski Pregled, 2015 Introduction. Spontaneous coronary artery dissection (SCAD) is a very rare disease with poor prognosis. It mainly affects young women free of risk factors for coronary artery disease (CAD) and women during the peripartum period.
Jović Zoran +6 more
doaj +1 more source
Newer fibrinolytic agents in patients with acute myocardial infarction
, 1986 Fibrinolytic agents with higher specificity for fibrin in the thrombi and little systemic activation of the fibrinolytic system have been developed and tested in preliminary clinical trials of patients with acute myocardial infarction.
E. Faioni, P. M. Mannucci
core +1 more source
The comparison of streptokinase, an old agent, versus reteplase for the re-tunnellisation of blocked cuffed haemodialysis catheter [PDF]
Scripta MedicaBackground/Aim: Catheter occlusion is the most common complication occurring in patients with end-stage renal disease (ESRD) who undergo haemodialysis. The management typically involves the use of local fibrinolytic agents. However, with the emergence of
Saroukhani Abbas, Omid Soheil
doaj +1 more source
Annals of Clinical and Translational Neurology, EarlyView.ABSTRACT Objectives Acute kidney injury (AKI) is a common but often underrecognized complication in ischemic stroke patients undergoing mechanical thrombectomy, particularly among those with pre‐existing renal impairment. This study evaluated the incidence, risk factors, and clinical impact of AKI in this high‐risk population.
Michał Borończyk +10 more
wiley +1 more source
Effects of fibrinolytic agents and heparin on intravascular clot lysis
, 1964 Clots were prepared in glass or siliconized cannulae and inserted into jugular veins 5 cm distal to semiconstricting ligatures. Clots prepared in glass tubes propagated rapidly unless heparin was administered.
Jessica H. Lewis +2 more
core +1 more source
Advanced Robotics Research, EarlyView.Micro‐ and nanorobots for targeted thrombolysis. This perspective elaborates on the clinical indication of blood clot disorders and current limitations for treatment. As a novel, alternative solution, micro‐ and nanorobots can be used to treat and break down thrombi.
Joshua M. Mesfin +3 more
wiley +1 more source
Strain Improvement of Streptomyces venezuelae for Enhanced Fibrinolytic Enzyme Production [PDF]
, 2020 : The fibrinolytic enzymes can be used as a potential drug to cure thrombosis diseases. These enzymes can effectively catalyze the degradation of fibrin in blood clot. To develop safe and cheaper fibrinolytic agents, fibrinolytic enzyme was isolated from
core